Kristine M. Eilers

1.2k total citations
13 papers, 958 citations indexed

About

Kristine M. Eilers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kristine M. Eilers has authored 13 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Kristine M. Eilers's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Kristine M. Eilers is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Kristine M. Eilers collaborates with scholars based in United States and Canada. Kristine M. Eilers's co-authors include Tomasz M. Beer, Motomi Mori, Yi‐Ching Hsieh, Erik K. Fromme, Mark Garzotto, W. David Henner, Merrill J. Egorin, Bruce A. Lowe, Christopher W. Ryan and Joshi J. Alumkal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Kristine M. Eilers

13 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristine M. Eilers United States	11	497	362	153	113	106	13	958
Anna Ceribelli Italy	15	577 1.2×	449 1.2×	132 0.9×	89 0.8×	159 1.5×	35	1.0k
Robin Stuart‐Harris Australia	17	415 0.8×	162 0.4×	129 0.8×	130 1.2×	88 0.8×	32	725
Ahmet Özet Türkiye	19	499 1.0×	301 0.8×	120 0.8×	96 0.8×	198 1.9×	153	1.3k
Phillip Blanchette Canada	16	615 1.2×	279 0.8×	156 1.0×	56 0.5×	106 1.0×	58	1.0k
Raquel E. Reinbolt United States	21	594 1.2×	206 0.6×	103 0.7×	131 1.2×	132 1.2×	56	1.1k
Inge R. Konings Netherlands	17	453 0.9×	220 0.6×	126 0.8×	228 2.0×	115 1.1×	42	1.0k
Nicolò Matteo Luca Battisti United Kingdom	21	922 1.9×	398 1.1×	223 1.5×	149 1.3×	109 1.0×	81	1.6k
Tracey L. O’Connor United States	17	944 1.9×	332 0.9×	218 1.4×	141 1.2×	195 1.8×	59	1.4k
P Murray United Kingdom	10	439 0.9×	164 0.5×	130 0.8×	52 0.5×	93 0.9×	15	682
Hikmat Abdel‐Razeq Jordan	17	481 1.0×	195 0.5×	235 1.5×	134 1.2×	138 1.3×	155	1.2k

Countries citing papers authored by Kristine M. Eilers

Since Specialization

Citations

This map shows the geographic impact of Kristine M. Eilers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine M. Eilers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine M. Eilers more than expected).

Fields of papers citing papers by Kristine M. Eilers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine M. Eilers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine M. Eilers. The network helps show where Kristine M. Eilers may publish in the future.

Co-authorship network of co-authors of Kristine M. Eilers

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine M. Eilers. A scholar is included among the top collaborators of Kristine M. Eilers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine M. Eilers. Kristine M. Eilers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tao, Derrick L., Tomasz M. Beer, Alice Fung, et al.. (2017). Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making. JCO Precision Oncology. 1(1). 1–11. 7 indexed citations

Beer, Tomasz M., Julie N. Graff, Kristine M. Eilers, et al.. (2016). Cyclooxygenase‐2 ( COX ‐2) inhibition for prostate cancer chemoprevention: double‐blind randomised study of pre‐prostatectomy celecoxib or placebo. British Journal of Urology. 119(5). 709–716. 21 indexed citations

Prins, R., Brooks L. Rademacher, Solange Mongoue‐Tchokote, et al.. (2010). C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results. Urologic Oncology Seminars and Original Investigations. 30(1). 33–37. 49 indexed citations

Beer, Tomasz M., et al.. (2010). A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy. Anti-Cancer Drugs. 21(4). 433–438. 32 indexed citations

Beer, Tomasz M., Sandra L. Emmons, Margaret M. Hayes, et al.. (2010). Acupuncture for Hot Flashes in Patients With Prostate Cancer. Urology. 76(5). 1182–1188. 40 indexed citations

Beer, Tomasz M., Alshad S. Lalani, Stella Lee, et al.. (2008). C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer. Cancer. 112(11). 2377–2383. 96 indexed citations

Beer, Tomasz M., Mark Garzotto, Byung Park, et al.. (2006). Effect of Calcitriol on Prostate-Specific Antigen In vitro and in Humans. Clinical Cancer Research. 12(9). 2812–2816. 13 indexed citations

Garzotto, Mark, et al.. (2005). Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer. Urology. 65(4). 799–799. 3 indexed citations

Beer, Tomasz M., Anne Myrthue, & Kristine M. Eilers. (2005). Rationale for the development and current status of calcitriol in androgen-independent prostate cancer. World Journal of Urology. 23(1). 28–32. 21 indexed citations

10.

Beer, Tomasz M., Kristine M. Eilers, Mark Garzotto, Yi‐Ching Hsieh, & Motomi Mori. (2004). Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen‐independent prostate carcinoma. Cancer. 100(4). 758–763. 19 indexed citations

11.

Fromme, Erik K., Kristine M. Eilers, Motomi Mori, Yi‐Ching Hsieh, & Tomasz M. Beer. (2004). How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30. Journal of Clinical Oncology. 22(17). 3485–3490. 422 indexed citations

12.

Beer, Tomasz M., et al.. (2003). Docetaxel (Taxotere®) in the treatment of prostate cancer. Expert Review of Anticancer Therapy. 3(3). 261–268. 34 indexed citations

13.

Beer, Tomasz M., Kristine M. Eilers, Mark Garzotto, et al.. (2002). Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer. Journal of Clinical Oncology. 21(1). 123–128. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact